Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer

Clinical Implications ◽

Hydroxyvitamin D ◽

25 Hydroxyvitamin D ◽

Faculty Opinions recommendation of Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734467013.793556634 ◽

2019 ◽

Author(s):

Eva Chalas

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Endocrine Therapy ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Hormone Receptor ◽

Adjuvant endocrine therapy impact on bone health in premenopausal women with hormone receptor-positive breast cancer: Results of a case series

Endocrine Abstracts ◽

10.1530/endoabs.73.aep145 ◽

2021 ◽

Author(s):

Diana Lambrinoc ◽

Duşceac Roxana ◽

Alexandru Morea ◽

Poiană Cătălina

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Bone Health ◽

Hormone Receptor ◽

Case Series ◽

Premenopausal Women ◽

Supplemental Material for Delay Discounting and Adjuvant Endocrine Therapy Adherence in Hormone Receptor-Positive Breast Cancer

Health Psychology ◽

10.1037/hea0001077.supp ◽

2021 ◽

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Delay Discounting ◽

Hormone Receptor ◽

Therapy Adherence ◽

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial

Annals of Oncology ◽

10.1093/annonc/mdw055 ◽

2016 ◽

Vol 27 (5) ◽

pp. 806-812 ◽

Cited By ~ 8

Author(s):

N. Zdenkowski ◽

J.F. Forbes ◽

F.M. Boyle ◽

G. Kannourakis ◽

P.G. Gill ◽

...

Keyword(s):

Breast Cancer ◽

Randomised Controlled Trial ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Controlled Trial ◽

Open Label ◽

Randomised Controlled ◽

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update

Journal of Oncology Practice ◽

10.1200/jop.18.00617 ◽

2019 ◽

Vol 15 (2) ◽

pp. 106-107 ◽

Cited By ~ 9

Author(s):

Harold J. Burstein ◽

Christina Lacchetti ◽

Jennifer J. Griggs

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Endocrine Therapy ◽

Clinical Practice Guideline ◽

Practice Guideline ◽

Hormone Receptor ◽

Abstract P1-12-13: Factors associated with adherence to adjuvant endocrine therapy in patients with hormone receptor positive breast cancer

10.1158/1538-7445.sabcs14-p1-12-13 ◽

2015 ◽

Author(s):

Jongjin Kim ◽

Wonshik Han ◽

Hyeong-Gon Moon ◽

Min Kyoon Kim ◽

Eunshin Lee ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Factors Associated ◽

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer

The Breast ◽

10.1016/j.breast.2013.07.033 ◽

2013 ◽

Vol 22 ◽

pp. S171-S175 ◽

Cited By ~ 14

Author(s):

Kathrin Strasser-Weippl ◽

Tanja Badovinac-Crnjevic ◽

Lei Fan ◽

Paul E. Goss

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Racial/ethnic difference in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e18076 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e18076-e18076

Author(s):

Albert Farias ◽

Xianglin L. Du

Keyword(s):

Breast Cancer ◽

Older Women ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Ethnic Difference ◽

Racial Ethnic ◽

Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05823-y ◽

2020 ◽

Vol 184 (1) ◽

pp. 63-74

Author(s):

Jessica S. Crystal ◽

Jamie Rand ◽

Jeffrey Johnson ◽

Sungjin Kim ◽

Reva Basho ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Breast Cancer Patients ◽

MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy

Oncotarget ◽

10.18632/oncotarget.11278 ◽

2016 ◽

Vol 7 (38) ◽

pp. 61166-61182 ◽

Cited By ~ 12

Author(s):

XiaoRong Zhong ◽

GuiQin Xie ◽

Zhang Zhang ◽

Zhu Wang ◽

Yu Wang ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Target Gene ◽

Prognostic Biomarkers ◽

Breast Cancer Patients ◽